Left Ventricular Assist Device (LVAD) Implantation and Renal Dysfunction

Имплантация вспомогательного устройства кровообращения левого желудочка и почечная дисфункция
Assem Nogaibayeva 1, Bagdat Sultanova 2, Myrzabek Makhmutov 3
More Detail
1 Extracorporeal Hemocorrection Laboratory, National Research Cardiac Surgery Center, Astana, Republic of Kazakhstan
2 Nephrology and Dialysis Department, Kazakh Medical University of Continuing Education, Almaty, Republic of Kazakhstan
3 Anesthesiology and Intensive Care Department (Adult), National Research Cardiac Surgery Center, Astana, Republic of Kazakhstan
J CLIN MED KAZ, Volume 3, Issue 49, pp. 15-23. https://doi.org/10.23950/1812-2892-JCMK-00578
OPEN ACCESS 3185 Views 3658 Downloads
Download Full Text (PDF)

ABSTRACT

Pathophysiological, pathomorphological and functional changes in the kidneys after left ventricular assist device implantation have not yet been fully understood and represent an actual problem of our time. Changes in renal function following left ventricular assist device implantation have been disclosed in many studies with inconsistent results. Some studies have shown that patients with renal dysfunction after left ventricular assist device implantation had worse outcomes, despite stabilization or even improvement of kidney function during the postoperative period, other studies have shown the progression of chronic kidney disease requiring renal replacement therapy.
Keywords: kidney, left ventricular assist device

CITATION

Nogaibayeva A, Sultanova B, Makhmutov M. Left Ventricular Assist Device (LVAD) Implantation and Renal Dysfunction. Journal of Clinical Medicine of Kazakhstan. 2018;3(49):15-23. https://doi.org/10.23950/1812-2892-JCMK-00578

REFERENCES

  • Tseng CC, Ramjankhan FZ, de Jonge N, Chamuleau SA. Advanced Strategies for EndStage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon? Front Surg. 2015;2:10. PubMed PMID: 25905105. PMCID: PMC4387859. Epub 2015/04/07. eng.
  • Benjamin EJ VS, Callaway CW, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD,, Ferguson JF FM, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu, S LC, Lutsey PL, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O’Flaherty M, Palaniappan LP, Pandey, DK RM, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL,, Tirschwell DL TC, Voeks JH, Willey JZ, Wilkins JT, Wu JHY, Alger HM, Wong SS, Muntner P. Heart Disease and Stroke Statistics—2018 Update A Report From the American Heart Association. Circulation; 20.03.2018. p. e67-e492.
  • Bloom MW, Greenberg B, Jaarsma T, Januzzi JL, Lam CSP, Maggioni AP, et al. Heart failure with reduced ejection fraction. Nat Rev Dis Primers. 2017 Aug;3:17058. PubMed PMID: 28836616. Epub 2017/08/24. eng.
  • Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006 May;47(10):1987-96. PubMed PMID: 1669731
  • Epub 2006/04/24. eng. 5. Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, et al. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 2012 Jan;59(1):26-36. PubMed PMID: 22192665. eng.
  • Hetzer R, Javier MFDM, Delmo Walter EM. Role of paediatric assist device in bridge to transplant. Ann Cardiothorac Surg. 2018 Jan;7(1):82-98. PubMed PMID: 29492386. PMCID: PMC5827126. eng.
  • Bloom RD. Renal function and nonrenal solid organ transplantation // http :// www . uptodate.com / contents / renal - function - and - nonrenal - solid - organ - transplantation. 2016.
  • Verma S, Bassily E, Leighton S, Mhaskar R, Sunjic I, Martin A, et al. Renal Function and Outcomes With Use of Left Ventricular Assist Device Implantation and Inotropes in End-Stage Heart Failure: A Retrospective Single Center Study. J Clin Med Res. 2017 Jul;9(7):596-604. PubMed PMID: 28611860. PMCID: PMC5458657. Epub 2017/05/22. eng.
  • Lund LH, Matthews J, Aaronson K. Patient selection for left ventricular assist devices. Eur J Heart Fail. 2010 May;12(5):434-43. PubMed PMID: 20172939. Epub 2010/02/19. eng.
  • Kiernan MS, Udelson JE, Sarnak M. Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology // http:// www.uptodate.com/contents/cardiorenal-syndromedefinition-prevalence-diagnosis-and-pathophysiology. 2018.
  • Di Lullo L, Bellasi A, Barbera V, Russo D, Russo L, Di Iorio B, et al. Pathophysiology of the cardio-renal syndromes types 1-5: An uptodate. Indian Heart J. 2017 2017 Mar - Apr;69(2):255-65. PubMed PMID: 28460776. PMCID: PMC5415026. Epub 2017/01/22. eng.
  • Soliman OII, Akin S, Muslem R, Boersma E, Manintveld OC, Krabatsch T, et al. Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk Score. Circulation. 2018 Feb;137(9):891-906. PubMed PMID: 28847897. Epub 2017/08/27. eng.
  • Left ventricular assist device. HeartMate III, Thoratec Corporation. User guide. HeartMate III 2017.
  • Stewart GC, Mehra MR. A history of devices as an alternative to heart transplantation. Heart Fail Clin. 2014 Jan;10(1 Suppl):S1-12. PubMed PMID: 24262348. Epub 2013/10/10. eng.
  • Slaughter MS, Meyer AL, Birks EJ. Destination therapy with left ventricular assist devices: patient selection and outcomes. Curr Opin Cardiol. 2011 May;26(3):232-6. PubMed PMID: 21430527. eng.
  • Sukehiro S, Flameng W. Effects of left ventricular assist for cardiogenic shock on cardiac function and organ blood flow distribution. Ann Thorac Surg. 1990 Sep;50(3):374-83. PubMed PMID: 2400257. eng.
  • Ahmad T, Wang T, O’Brien EC, Samsky MD, Pura JA, Lokhnygina Y, et al. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. JACC Heart Fail. 2015 Jan;3(1):30-9. PubMed PMID: 25447345. Epub 2014/11/12. eng.
  • Butler J, Geisberg C, Howser R, Portner PM, Rogers JG, Deng MC, et al. Relationship between renal function and left ventricular assist device use. Ann Thorac Surg. 2006 May;81(5):1745-51. PubMed PMID: 16631666. eng.
  • Letsou GV, Myers TJ, Gregoric ID, Delgado R, Shah N, Robertson K, et al. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann Thorac Surg. 2003 Oct;76(4):1167-70. PubMed PMID: 14530006. eng.
  • Ambardekar AV, Buttrick PM. Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects. Circ Heart Fail. 2011 Mar;4(2):224-33. PubMed PMID: 21406678. PMCID: PMC3385856. eng.
  • Flaherty MP, Pant S, Patel SV, Kilgore T, Dassanayaka S, Loughran JH, et al. Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention. Circ Res. 2017 Feb;120(4):692-700. PubMed PMID: 28073804. Epub 2017/01/10. eng.
  • Nemoto M. Experimental evaluation of the influence of complete artificial circulation on renal circulation and tissue metabolism – comparative study of pulsatile vs. nonpulsatile circulation. Ann Thorac Cardiovasc Surg 2003. p. 355–64.
  • Nagasaka F, Hasegawa T, Shiono M, Orime Y, Sezai Y. New sequential synchronized driving system of intraaortic balloon pumping and left ventricular assist device: influence on endocardial viability ratio and renal blood flow in their combination. Artif Organs. 1992 Apr;16(2):216-8. PubMed PMID: 10078249. eng.
  • Iwashima Y, Yanase M, Horio T, Seguchi O, Murata Y, Fujita T, et al. Effect of pulsatile left ventricular assist system implantation on Doppler measurements of renal hemodynamics in patients with advanced heart failure. Artif Organs. 2012 Apr;36(4):353-8. PubMed PMID: 21995604. Epub 2011/10/14. eng.
  • Ootaki C, Yamashita M, Ootaki Y, Kamohara K, Weber S, Klatte RS, et al. Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. J Thorac Cardiovasc Surg. 2008 Jul;136(1):150-8. PubMed PMID: 18603068. PMCID: PMC2533270. Epub 2008/05/19. eng.
  • Mao H, Katz N, Kim JC, Day S, Ronco C. Implantable left ventricular assist devices and the kidney. Blood Purif. 2014;37(1):57- 66. PubMed PMID: 24525434. Epub 2014/02/12. eng.
  • Grosman-Rimon L, McDonald MA, Freedman D, Yip P, Cherney DZ, Rao V. Neurohormone levels remain elevated in continuous flow left ventricular assist device recipients. J Card Surg. 2018 Jun. PubMed PMID: 29900585. Epub 2018/06/14. eng. 
  • Imamura T, Kinugawa K, Nitta D, Fujino T, Inaba T, Maki H, et al. Lower rotation speed stimulates sympathetic activation during continuous-flow left ventricular assist device treatment. J Artif Organs. 2015 Mar;18(1):20-6. PubMed PMID: 25337982. Epub 2014/10/22. eng.
  • Markham DW, Fu Q, Palmer MD, Drazner MH, Meyer DM, Bethea BT, et al. Sympathetic neural and hemodynamic responses to upright tilt in patients with pulsatile and nonpulsatile left ventricular assist devices. Circ Heart Fail. 2013 Mar;6(2):293-9. PubMed PMID: 23250982. Epub 2012/12/18. eng.
  • Ambardekar AV, Hunter KS, Babu AN, Tuder RM, Dodson RB, Lindenfeld J. Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study. Circ Heart Fail. 2015 Sep;8(5):944-52. PubMed PMID: 26136459. Epub 2015/07/01. eng.
  • Hasin T, Grupper A, Dillon JJ, Maleszewski JJ, Li Z, Topilsky Y, et al. Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May Not Persist to One Year. ASAIO J. 2017 2017 Jul/Aug;63(4):401-7. PubMed PMID: 28114196. eng.
  • Mohamedali B, Bhat G. The Influence of Pre-Left Ventricular Assist Device (LVAD) Implantation Glomerular Filtration Rate on Long-Term LVAD Outcomes. Heart Lung Circ. 2017 Nov;26(11):1216-23. PubMed PMID: 28342643. Epub 2017/02/17. eng.
  • Miyamoto T, Karimov JH, Fukamachi K. Effects of continuous and pulsatile flows generated by ventricular assist devices on renal function and pathology. Expert Rev Med Devices. 2018 Mar;15(3):171-82. PubMed PMID: 29400088. Epub 2018/02/09. eng.
  • Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuousflow left ventricular assist device. N Engl J Med. 2009 Dec;361(23):2241-51. PubMed PMID: 19920051. Epub 2009/11/17. eng.
  • Singh M, Shullo M, Kormos RL, Lockard K, Zomak R, Simon MA, et al. Impact of renal function before mechanical circulatory support on posttransplant renal outcomes. Ann Thorac Surg. 2011 May;91(5):1348-54. PubMed PMID: 21524442. eng.
  • Tsiouris A, Morgan JA, Nemeh HW, Hodari A, Shah R, Brewer RJ, et al. Does elective or emergent operative status influence outcomes in patients undergoing implantation of left ventricular assist devices? Heart Surg Forum. 2014 Apr;17(2):E64-72. PubMed PMID: 24808443. eng.
  • Muslem R, Caliskan K, Akin S, Yasar YE, Sharma K, Gilotra NA, et al. Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation. Am J Cardiol. 2017 Dec;120(12):2221-5. PubMed PMID: 29037445. Epub 2017/09/20. eng.
  • Rosenbaum AN, John R, Liao KK, Adatya S, Colvin-Adams MM, Pritzker M, et al. Survival in elderly patients supported with continuous flow left ventricular assist device as bridge to transplantation or destination therapy. J Card Fail. 2014 Mar;20(3):161- 7. PubMed PMID: 24412524. Epub 2014/01/09. eng.
  • Yoshioka D, Toda K, Ono M, Nakatani T, Shiose A, Matsui Y, et al. Clinical Results, Adverse Events, and Change in EndOrgan Function in Elderly Patients With HeartMateII Left Ventricular Assist Device - Japanese Multicenter Study. Circ J. 2018 Jan;82(2):409-18. PubMed PMID: 29057766. Epub 2017/10/21. eng.